Prospective, Randomized, Open label Controlled trial to evaluate the safety and efficacy of Dexmedetomidine Compared with Midazolam in children admitted to Pediatric Intensive Care unit (PICU) at KAMC-NGHA

drug protocol number
RC11/084/R
drug sponsor
KAIMRC
drug study
Dexmedetomidine (Precedex)
drug trial site
NGHA-R
drug status
Rejected
drug phase